References:
1. Teh BL, Khan MK, Butt A, Kuffova L. Bilateral ocular involvement with syphilis in a known HIV patient. Am J Ophthalmol Case Rep . 2020;18:100638. doi:10.1016/j.ajoc.2020.100638
2. Albini T, Callaway NF, Pershing S, Wang SK, Moshfeghi AA, Moshfeghi DM. Trends in Hospitalization and Incidence Rate for Syphilitic Uveitis in the United States From 1998 to 2009. Am J Ophthalmol . 2017;180:133-141. doi:10.1016/j.ajo.2017.05.013
3. Schulz DC, Orr SMA, Johnstone R, Devlin MK, Sheidow TG, Bursztyn LLCD. The many faces of ocular syphilis: case-based update on recognition, diagnosis, and treatment. Can J Ophthalmol . Published online February 2021:S0008418221000168. doi:10.1016/j.jcjo.2021.01.006
4. Kiss S, Damico FM, Young LH. Ocular Manifestations and Treatment of Syphilis. Semin Ophthalmol . 2005;20(3):161-167. doi:10.1080/08820530500232092
5. Eslami M. Resurgence of ocular syphilis in British Columbia between 2013–2016: a retrospective chart review. 2020;55(2):6.
6. Anthony J. Aldave, MD,* Julie A. King, MD,† and Emmett T. Cunningham, Jr., MD, PhD, MPH*. Ocular syphilis. Curr Opin Ophthalmol . 2001;12(6):433-441. doi:10.1097/00055735-200112000-00008
7. Moradi A, Salek S, Daniel E, et al. Clinical Features and Incidence Rates of Ocular Complications in Patients With Ocular Syphilis. Am J Ophthalmol . 2015;159(2):334-343.e1. doi:10.1016/j.ajo.2014.10.030
8. Furtado JM, Arantes TE, Nascimento H, et al. Clinical Manifestations and Ophthalmic Outcomes of Ocular Syphilis at a Time of Re-Emergence of the Systemic Infection. Sci Rep . 2018;8(1):12071. doi:10.1038/s41598-018-30559-7
9. Tsuboi M, Nishijima T, Yashiro S, et al. Time to development of ocular syphilis after syphilis infection. J Infect Chemother . 2018;24(1):75-77. doi:10.1016/j.jiac.2017.08.006